Literature DB >> 18287136

Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.

Shinsaku Imashuku1, Yoko Shioda, Ryoji Kobayashi, Gaku Hosoi, Hisanori Fujino, Shiro Seto, Hisashi Wakita, Akira Oka, Nagisa Okazaki, Naoto Fujita, Toshinori Minato, Kenichi Koike, Yukiko Tsunematsu, Akira Morimoto.   

Abstract

Clinical features, brain magnetic resonance imaging findings and EDSS scores of 11 patients with neurodegenerative central nervous system Langerhans cell histiocytosis were analyzed in Japan. All patients initially had multi-system-type Langerhans cell histiocytosis; 8 at 1-2 years of age and 3 at a later age. Neurodegenerative central nervous system Langerhans cell histiocytosis disease developed after a median time interval of 3.9 years from initial diagnosis. With a median follow-up of 4.5 years, 6 patients showed progression of disease with an EDSS score >3. This study demonstrates the importance of early detection of neurodegenerative central nervous system Langerhans cell histiocytosis by brain magnetic resonance imaging, particularly in the follow-up of patients who developed multi-system-type Langerhans cell histiocytosis in early infancy.

Entities:  

Mesh:

Year:  2008        PMID: 18287136     DOI: 10.3324/haematol.11827

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.

Authors:  Yoko Shioda; Souichi Adachi; Shinsaku Imashuku; Kazuko Kudo; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

2.  Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.

Authors:  Akira Morimoto; Yoko Shioda; Toshihiko Imamura; Kazuko Kudo; Toshiyuki Kitoh; Hiroshi Kawaguchi; Hiroaki Goto; Yoshiyuki Kosaka; Yukiko Tsunematsu; Shinsaku Imashuku
Journal:  Int J Hematol       Date:  2018-03-28       Impact factor: 2.490

3.  Langerhans Cell Histiocytosis Presenting With Late-Onset Sporadic Ataxia.

Authors:  Inder Puri; Divyani Garg; Achal Kumar Srivastava; Lavleen Singh; Garima Shukla; Vinay Goyal
Journal:  Mov Disord Clin Pract       Date:  2019-09-18

4.  Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.

Authors:  Sophie Ng Wing Tin; Nadine Martin-Duverneuil; Ahmed Idbaih; Catherine Garel; Maria Ribeiro; Judith Landman Parker; Anne-Sophie Defachelles; Anne Lambilliotte; Mohamed Barkaoui; Martine Munzer; Martine Gardembas; Jean Sibilia; Patrick Lutz; Renato Fior; Michel Polak; Alain Robert; Olivier Aumaitre; Dominique Plantaz; Corinne Armari-Alla; Thierry Genereau; Perrine Marec Berard; Ghislain Nokam Talom; Jean-Loup Pennaforte; Hubert Ducou Le Pointe; Marie-Anne Barthez; Gérard Couillault; Julien Haroche; Karima Mokhtari; Jean Donadieu; Khê Hoang-Xuan
Journal:  Orphanet J Rare Dis       Date:  2011-12-12       Impact factor: 4.123

5.  A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening.

Authors:  Nicholas A Tritos; Thomas N Byrne; Chin-Lee Wu; Anne Klibanski
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

6.  Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.

Authors:  Shinsaku Imashuku; Naoto Fujita; Yoko Shioda; Haruyoshi Noma; Shiro Seto; Toshinori Minato; Kazuo Sakashita; Nobuhiro Ito; Ryoji Kobayashi; Akira Morimoto
Journal:  Int J Hematol       Date:  2014-12-10       Impact factor: 2.490

7.  Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems.

Authors:  Shinsaku Imashuku; Naoko Kinugawa; Akinobu Matsuzaki; Toshiyuki Kitoh; Kentaro Ohki; Yoko Shioda; Yukiko Tsunematsu; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2009-09-25       Impact factor: 2.490

8.  The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial.

Authors:  Xiao Han; Mingqi Ouyang; Minghui Duan; Wei Zhang; Tienan Zhu; Jian Li; Shujie Wang; Daobin Zhou
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

9.  Langerhans Cell Histiocytosis in the Adult Lumbar Spine - A Case Report and Literature Review.

Authors:  Charanjit Singh Dhillon; Raviraj Tantry; Shrikant Rajeshwari Ega; Chetan Pophale; Narendra Reddy Medagam; Nilay Chhasatia
Journal:  J Orthop Case Rep       Date:  2020-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.